Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
IRWD
IRWD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
IRWD News
Regulatory Approvals and Collaborations in Biotech Sector
2d ago
NASDAQ.COM
FDA Approves LINZESS for Pediatric Functional Constipation Treatment
3d ago
NASDAQ.COM
FDA Approves Linzess Label Expansion for Children
4d ago
seekingalpha
FDA Approves LINZESS for Pediatric Constipation Treatment
4d ago
NASDAQ.COM
FDA Approves LINZESS for Pediatric Functional Constipation in Ages 2-5
4d ago
Newsfilter
Healthcare ETF Underperforms Amid Earnings Season
5d ago
seekingalpha
Ironwood Pharmaceuticals Appoints Interim CFO, Shares Drop 12%
May 13 2026
seekingalpha
Ironwood Pharmaceuticals Q1 2026 Earnings Call Insights
May 08 2026
seekingalpha
Ironwood Pharmaceuticals to Announce Q1 Earnings on May 7
May 06 2026
seekingalpha
Ironwood Pharmaceuticals to Present New Data at Digestive Disease Week
Apr 23 2026
Newsfilter
Ironwood (IRWD) Q4 2025 Earnings Call Transcript
Feb 25 2026
NASDAQ.COM
Ironwood Pharmaceuticals Q4 Earnings Miss Expectations
Feb 25 2026
seekingalpha
Ironwood Reports 2025 Financial Highlights and 2026 Guidance
Feb 25 2026
Newsfilter
Trump Announces U.S. Oil Companies to Invest Billions in Venezuela Post-Maduro
Jan 05 2026
Benzinga
Health Care Stocks Mixed as NYSE Health Care Index Edges Up
Jan 02 2026
Yahoo Finance
Intelligent Bio Solutions Plans $10 Million Private Placement, Shares Plunge 19.7%
Jan 02 2026
Benzinga
Show More News
